486 related articles for article (PubMed ID: 23884752)
1. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
3. [Cystic pancreatic tumors: diagnostics and new biomarkers].
Berger AW; Seufferlein T; Kleger A
Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
[TBL] [Abstract][Full Text] [Related]
4. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Thosani N; Dasari CS; Bhutani MS; Raimondo M; Guha S
Pancreas; 2010 Nov; 39(8):1129-33. PubMed ID: 20881900
[TBL] [Abstract][Full Text] [Related]
6. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
El Gammal AT; Izbicki JR
Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
[TBL] [Abstract][Full Text] [Related]
7. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
8. [Cystic and intraductal tumors of the pancreas].
Le Borgne J
Rev Prat; 2002 Sep; 52(14):1540-5. PubMed ID: 12412301
[TBL] [Abstract][Full Text] [Related]
9. [Strategy in intraductal papillary mucinous neoplasm of the pancreas].
Navarro Colás S; Vaquero Raya EC
Gastroenterol Hepatol; 2012 Nov; 35(9):652-9. PubMed ID: 22832084
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
12. Cystic and ductal tumors of the pancreas: diagnosis and management.
Scoazec JY; Vullierme MP; Barthet M; Gonzalez JM; Sauvanet A
J Visc Surg; 2013 Apr; 150(2):69-84. PubMed ID: 23518192
[TBL] [Abstract][Full Text] [Related]
13. Benign, premalignant and malignant pancreatic cystic lesions: the pathology landscape.
Demetter P; Verset L
Acta Gastroenterol Belg; 2017; 80(2):293-298. PubMed ID: 29560696
[TBL] [Abstract][Full Text] [Related]
14. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
15. Management of cystic and solid pancreatic incidentalomas: a review analysis.
Karatzas T; Dimitroulis D; Charalampoudis P; Misiakos EP; Vasileiadis I; Kouraklis G
J BUON; 2013; 18(1):17-24. PubMed ID: 23613384
[TBL] [Abstract][Full Text] [Related]
16. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
Theisen BK; Wald AI; Singhi AD
Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
19. Cystic pancreatic neoplasms: observe or operate.
Spinelli KS; Fromwiller TE; Daniel RA; Kiely JM; Nakeeb A; Komorowski RA; Wilson SD; Pitt HA
Ann Surg; 2004 May; 239(5):651-7; discussion 657-9. PubMed ID: 15082969
[TBL] [Abstract][Full Text] [Related]
20. Premalignant cystic neoplasms of the pancreas.
Dudeja V; Allen PJ
Semin Oncol; 2015 Feb; 42(1):70-85. PubMed ID: 25726053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
